Clinical & Pharma

Can Cyclophosphamide Revolutionize Blood Stem Cell Transplants?
Clinical & Pharma Can Cyclophosphamide Revolutionize Blood Stem Cell Transplants?

The landscape of medical treatment for blood cancer patients is witnessing a transformative shift, thanks to innovative research on blood stem cell transplants. This research particularly delves into the safety and efficacy of "mismatched" transplants, a domain that has historically posed

Unlocking Excellence in Specialty Pharmacy Partnerships
Clinical & Pharma Unlocking Excellence in Specialty Pharmacy Partnerships

Specialty pharmacies are integral components of the healthcare landscape, particularly in delivering innovative pharmaceutical treatments for rare, chronic, and complex conditions. These pharmacies must go beyond traditional drug dispensing to ensure life-saving medications reach patients who need

HPV Epidemiology in Southwest China: 2014–2024 Male Trends
Clinical & Pharma HPV Epidemiology in Southwest China: 2014–2024 Male Trends

Over an 11-year period, a rigorous study examined the molecular epidemiology of human papillomavirus (HPV) among males in the plateau region of Southwest China, illuminating essential trends and insights into public health needs. This endeavor aimed to decipher the prevalence, genotype

Embedding Health Services Research in Australian Healthcare
Clinical & Pharma Embedding Health Services Research in Australian Healthcare

Australia is grappling with a critical healthcare challenge where access to essential services lags significantly behind other nations, as underlined by its ninth-place ranking in a recent international healthcare systems report. At the core of addressing this pressing issue is the effective

Maxona Advances Non-Opioid Pain Therapy with SAB Formation
Clinical & Pharma Maxona Advances Non-Opioid Pain Therapy with SAB Formation

The battle against chronic pain and the opioid crisis has reached a critical juncture, with the medical community in dire need of non-opioid alternatives that combine efficacy and safety. In this context, MAXONA Pharmaceuticals is making strides by establishing a Scientific Advisory Board (SAB) and

How Can Canada Curb Rising Carbapenemase-Producing Infections?
Clinical & Pharma How Can Canada Curb Rising Carbapenemase-Producing Infections?

The rise of carbapenemase-producing Enterobacterales (CPE) within Canadian hospitals underscores a pressing public health challenge, aligning with global incidences of antimicrobial resistance. The exponential increase in both infection and colonization rates over the years from 2010 to 2023

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later